免疫抑制剂/免疫调节剂和恶性病变
Norishige Iizuka1, Yoshihiko Hoshida2, Atsuko Tsujii Miyamoto3,4
1Department of Pathology, Kishiwada City Hospital, Kishiwada 596-8501, Osaka, Japan.
Journal of clinical medicine
|July 29, 2025
概括
免疫抑制会增加癌症的风险,特别是与病毒相关的恶性瘤. 使用的免疫抑制药物的类型显著影响这些癌症的特征,包括淋巴增殖性疾病.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 免疫抑制会增加恶性瘤的风险,原因是瘤免疫力减弱和病毒激活.
- 免疫抑制个体的恶性瘤往往是侵略性的和与病毒相关的.
- 免疫抑制剂影响癌症的类型,频率和临床病理特征.
研究的目的:
- 探索免疫抑制性瘤,特别是淋巴增殖性疾病 (LPD) 的不断变化的临床病理学特征.
- 了解不同的免疫抑制剂/免疫调节剂如何影响移植后的LPD和类风湿性关节炎相关的LPD (RA-LPD).
主要方法:
- 对免疫抑制和恶性瘤现有文献的综述.
- 在器官移植接受者和RA患者中分析LPD的临床病理特征.
- 腰部疾病特征与特定的免疫抑制药物治疗方案的相关性.
主要成果:
- 移植后恶性瘤根据免疫抑制药物类型而异.
- 甲托雷克萨特 (MTX) 与MTX相关的LPD有关.
- 根据同时使用的抗RA药物,如塔克罗利斯和TNF抑制剂,RA-LPD特征有所不同.
结论:
- 移植后LPD和RA-LPD的临床病理特征是动态的,受到免疫抑制剂/免疫调节剂的影响.
- 了解这些不断变化的趋势对于免疫抑制性瘤的有效临床管理至关重要.
更多相关视频
相关概念视频
Tumor Immunotherapy
662
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
662
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
271
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
271
Immunodeficiency Diseases
1.2K
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
There are three main causes of immunodeficiency...
1.2K
Cell-mediated Immune Responses
72.9K
Overview
72.9K
Pulmonary Tuberculosis I
326
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
326
Mitogens and the Cell Cycle
6.9K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.9K


